Posted by barbarahales
An article published in House Calls by Dr. Stengler highlights the problems with drugs approved by the FDA (Federal Drug Administration) and the reports compiled about adverse reactions only after they have been approved and taken by the unsuspecting public. See below: “Up to 50% of all drug side effects — including dangerous and even [...]
Posted by barbarahales
We have often seen that for many businesses, when following a code of ethics translates to losing money, their mantra is “there is no ethics in business”. Apparently this is what Glaxo- Smith-Klein subscribes to. In doing their comparison study between Avandia and Actos for diabetes, the cardiovascular risk and death came to light. Instead [...]
- July 13th
- Filed under: Uncategorized
- Tags: actos, avandia, business ethic, drug safety, drug warning, ethics, FDA, glaxo smith klein, GSK, patient safety, public warning
